Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

Condition:   Combined Hepatocellular Cholangiocarcinoma Intervention:   Drug: gemcitabine ,oxaliplatin,anlotinib,Sintilimab Sponsor:   Sichuan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials